Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Microcap & Penny Stocks : Rat dog micro-cap picks... -- Ignore unavailable to you. Want to Upgrade?

To: Bucky Katt who wrote (5958)	10/10/2001 10:58:41 AM
From: Evan	Read Replies (1) \| Respond to of 48461

Did IAMR strike gold? lets keep it to ourselves :-)

To: Bucky Katt who wrote (5958)	10/10/2001 11:09:15 AM
From: Joe Smith	Read Replies (1) \| Respond to of 48461

William, what do yo think of Energy rats and alternative energy? Isn't an oil shock quite likely with all of the unrest?

To: Bucky Katt who wrote (5958)	10/10/2001 11:13:10 AM
From: tsigprofit	Read Replies (1) \| Respond to of 48461

William - did you see old rat MILT? bigcharts.marketwatch.com I didn't have any :-( but thought you or some of our thread members may still... PVAT has done well..I'm still holding that. One of my speculative ones - EBNK - not really a rat (but I play with the rat buy method) has been doing well recently. Got some at 6 cents - it's at 16 today. This one is really wild (and mucho speculative) but I like the chart: bigcharts.marketwatch.com Got in late with your INVN, VISG, VSNX security rats. Holding long-term positions in each now though. You were certainly right on those! Congrats. This is the best SI thread. Matt

To: Bucky Katt who wrote (5958)	12/13/2002 9:36:47 AM
From: xcr600	Read Replies (1) \| Respond to of 48461

07:09 ET Siga Tech could become key player in biowarfare defense -- B-Week (SIGA) 1.65: Business Week reports that stk's recent rise from $1.00 reflects the role of Siga in developing a smallpox antiviral drug. Co's research has captured the interest of the U.S. military, which has granted $1.6 mln to Siga to develop a smallpox drug, say sources close to the situation. According to article, Siga's animal testing will begin early next year, and a drug could be approved in two yrs. A Global Partners analyst rates the stock Speculative Buy and has a 12-month price target of $4 to $5.